Market revenue in 2022 | USD 211.0 million |
Market revenue in 2030 | USD 370.8 million |
Growth rate | 7.3% (CAGR from 2022 to 2030) |
Largest segment | Dermal fillers |
Fastest growing segment | Ophthalmic |
Historical data | 2017 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Dermal Fillers, Osteoarthritis, Ophthalmic, Vesicoureteral Reflux |
Key market players worldwide | Allergan, Sanofi SA, Anika Therapeutics Inc, Bausch Health Companies Inc, Roche Holding AG ADR, Nestle SA, Zimmer Biomet Holdings Inc, Smith & Nephew PLC, Ferring, Lifecore Biomedical Inc, Shiseido Co Ltd, Bloomage BioTechnology, LG Chem, Maruha Nichiro Corp, Genzyme, Seikagaku, HTL Biotechnology |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to hyaluronic acid market will help companies and investors design strategic landscapes.
Dermal fillers was the largest segment with a revenue share of 41.9% in 2022. Horizon Databook has segmented the UK hyaluronic acid market based on dermal fillers, osteoarthritis, ophthalmic, vesicoureteral reflux covering the revenue growth of each sub-segment from 2017 to 2030.
Increasing adoption and growing popularity of cosmetic procedures in young generation as well as easy availability of dermal fillers are among factors fueling market growth in the UK. There are more than 160 types of dermal fillers available in the UK.
Increasing spending capacity of the people and availability of surplus income of middle-class population to spend on esthetic procedures are among factors boosting the adoption of hyaluronic acid-based dermal fillers.
The prevalence of osteoarthritis in the UK is high. According to Arthritis Research UK, nearly one in five adults aged over 45 in England have osteoarthritis of the knee and one in nine adults have osteoarthritis of the hip.
Horizon Databook provides a detailed overview of country-level data and insights on the UK hyaluronic acid market , including forecasts for subscribers. This country databook contains high-level insights into UK hyaluronic acid market from 2017 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account